Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7633)
All Articles published online
|
Publishing Process of This Article
|
Jul 15, 2019 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ntavatzikos A, Spathis A, Patapis P, Machairas N, Vourli G, Peros G, Papadopoulos I, Panayiotides I, Koumarianou A. TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer. World J Gastrointest Oncol 2019; 11(7): 551-566 [PMID: 31367274 DOI: 10.4251/wjgo.v11.i7.551] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i7/551.htm |
| Number | Citing Articles |
| 1 |
Qiang Tang, Xin Hu, Qiong Guo, Yueyue Shi, Liming Liu, Guoguang Ying. Discovery and Validation of a Novel Metastasis-Related lncRNA Prognostic Signature for Colorectal Cancer. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.704988
|
| 2 |
Shamin Azwar, Heng Fong Seow, Maha Abdullah, Mohd Faisal Jabar, Norhafizah Mohtarrudin. Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment. Biology 2021; 10(9): 854 doi: 10.3390/biology10090854
|
| 3 |
Liusheng Li, Qian Qu, Ning Cui, Linlin Cai, Jianhua Zou, Jiao Wu, Tengteng Hao, Yu Wu. Efficacy of jianpi huatan granule in reducing colorectal cancer metastasis and recurrence after radical resection and adjuvant chemotherapy: Study protocol for a randomised, double-blind, placebo-controlled, multicentre trial. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.944475
|
| 4 |
Zijun Yan, Jie Xia, Ziyang Cao, Hongyang Zhang, Jinxia Wang, Tienan Feng, Yi Shu, Lin Zou. Multi-omics integration reveals potential stage-specific druggable targets in T-cell acute lymphoblastic leukemia. Genes & Diseases 2024; 11(5): 100949 doi: 10.1016/j.gendis.2023.03.022
|
| 5 |
Min Zhang, Tianhui Chen. Overview on population screening for carriers with germline mutations in mismatch repair (MMR) genes in China. Hereditary Cancer in Clinical Practice 2021; 19(1) doi: 10.1186/s13053-021-00182-1
|
| 6 |
Shanzhi Wan, Zhimin Liu, Yang Chen, Zhitao Mai, Mingming Jiang, Qingguo Di, Baohua Sun. MicroRNA-140-3p represses the proliferation, migration, invasion and angiogenesis of lung adenocarcinoma cells via targeting TYMS (thymidylate synthetase). Bioengineered 2021; 12(2): 11959 doi: 10.1080/21655979.2021.2009422
|
| 7 |
Xinkun Huang, Yang Cao, Peng Bao, Bingye Zhu, Zhouyang Cheng. High expression ofPI4K2Apredicted poor prognosis of colon adenocarcinoma (COAD) and correlated with immunity. Cancer Medicine 2023; 12(1): 837 doi: 10.1002/cam4.4895
|
| 8 |
Li Guo, Yaodong Zhang, Zibo Yin, Yaya Ji, Guowei Yang, Bowen Qian, Sunjing Li, Jun Wang, Tingming Liang, Changxian Li, Xiangcheng Li. Screening and identification of genes associated with cell proliferation in cholangiocarcinoma. Aging 2020; 12(3): 2626 doi: 10.18632/aging.102766
|
| 9 |
Aziz A. A. Alnakli, Abidali Mohamedali, Benjamin Heng, Charles Chan, Joo-Shik Shin, Michael Solomon, Pierre Chapuis, Gilles J. Guillemin, Mark S. Baker, Seong Beom Ahn. Protein prognostic biomarkers in stage II colorectal cancer: implications for post-operative management. BJC Reports 2024; 2(1) doi: 10.1038/s44276-024-00043-z
|
| 10 |
Henu Kumar Verma, Yashwant Kumar Ratre, Pellegrino Mazzone. Colon Cancer Diagnosis and Therapy Vol. 3. 2022; : 123 doi: 10.1007/978-3-030-72702-4_7
|
| 11 |
Jinsong Su, Baiyun Dai, Weitang Yuan, Guixian Wang, Zhiyong Zhang, Zhen Li, Jinbo Liu, Junmin Song. The influence of PD-L1 genetic variation on the prognosis of R0 resection colorectal cancer patients received capecitabine-based adjuvant chemotherapy: a long-term follow-up, real-world retrospective study. Cancer Chemotherapy and Pharmacology 2020; 85(5): 969 doi: 10.1007/s00280-020-04069-1
|
| 12 |
Charalampia Ioannou, Georgia Ragia, Ioanna Balgkouranidou, Nikolaos Xenidis, Kyriakos Amarantidis, Triantafyllia Koukaki, Eirini Biziota, Stylianos Kakolyris, Vangelis G Manolopoulos.
Gender-Dependent Association of
Tyms
-TSER Polymorphism With 5-Fluorouracil or Capecitabine-Based Chemotherapy Toxicity
. Pharmacogenomics 2021; 22(11): 669 doi: 10.2217/pgs-2021-0031
|
| 13 |
Paerhati Shayimu, Aikeremu Yusufu, Aizimaiti Rehemutula, Darebai Redati, Rexida Jiapaer, Rousidan Tuerdi. MTBP promoted the proliferation, migration and invasion of colon cancer cells by activating the expression of ZEB2. Animal Cells and Systems 2021; 25(3): 152 doi: 10.1080/19768354.2021.1938218
|
| 14 |
Zhengyong Xie, Yongli Ke, Zehang Li, Junyong Chen, Deqiao Lei, Guijin Chen, Changzheng Wang, Yuhong Chen, Hongliang Ding, Liyang Cheng. GRIK5 stimulates colon cancer growth and metastasis through cAMP/PKA/CADM3 signaling. Cell Biology International 2023; 47(7): 1259 doi: 10.1002/cbin.12022
|
| 15 |
Michela Roberto, Giulia Arrivi, Emanuela Pilozzi, Andrea Montori, Genoveffa Balducci, Paolo Mercantini, Andrea Laghi, Debora Ierinò, Martina Panebianco, Daniele Marinelli, Silverio Tomao, Paolo Marchetti, Federica Mazzuca. The Potential Role of Genomic Signature in Stage II Relapsed Colorectal Cancer (CRC) Patients: A Mono-Institutional Study. Cancer Management and Research 2022; : 1353 doi: 10.2147/CMAR.S342612
|
| 16 |
Bo Cheng, Aimei Rong, Quanbo Zhou, Wenlu Li. LncRNA LINC00662 promotes colon cancer tumor growth and metastasis by competitively binding with miR-340-5p to regulate CLDN8/IL22 co-expression and activating ERK signaling pathway. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-019-1510-7
|
| 17 |
Irina Nakashidze, Nina Petrović, Nino Kedelidze, Begum Dariya. Colon Cancer Diagnosis and Therapy Vol. 3. 2022; : 69 doi: 10.1007/978-3-030-72702-4_4
|
| 18 |
Karolina Juszczyk, Mohamed Zaafer Afzal, Timothy Ganguly, Thu‐Lan Kelly, Robyn Zeelie, Elizabeth Mary Ann Murphy. Evaluating whether KRAS/BRAF mutation status, anaemia and obstruction are associated with recurrence and mortality in non‐metastatic colorectal cancer. ANZ Journal of Surgery 2023; 93(10): 2457 doi: 10.1111/ans.18470
|
| 19 |
Juan Pablo Cayún, Leslie Carol Cerpa, Alicia Colombo, Dante Daniel Cáceres, José Luis Leal, Felipe Reyes, Carolina Gutiérrez-Cáceres, Susan Calfunao, Nelson Miguel Varela, Luis Abel Quiñones. Genetic Polymorphisms and Tumoral Mutational Profiles over Survival in Advanced Colorectal Cancer Patients: An Exploratory Study. Current Oncology 2024; 31(1): 274 doi: 10.3390/curroncol31010018
|